Sign In
Buy ARVN
$7.70
-0.300 (-3.75%)
At Close: Jun 03, 2026
Carvana Co Ranked Among Today's Top Shorts
12:10pm, Monday, 16'th Aug 2021
Markets were in the red this morning by just shy of 1% across the board. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Arvinas Inc Ranked Among Today's Top Shorts
11:17am, Thursday, 12'th Aug 2021
Markets were slightly lower this morning after the Dow Jones touched all-time highs at the open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Arvinas Inc Ranked Among Today's Top Shorts
11:11am, Tuesday, 10'th Aug 2021
The Dow Jones rose 10 points, while both the S&P 500 and Nasdaq also saw mild gains. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
09:16am, Monday, 09'th Aug 2021
HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augment
Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates
12:10pm, Thursday, 05'th Aug 2021
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -22.62% and 2.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Arvinas: Tremendous Value Increase With Pfizer Mega-Deal, High Potential
11:00pm, Saturday, 31'st Jul 2021
ARVN is a pioneering protein degrader biopharma with strong early data. Recently, Pfizer inked a $2bn deal with the company for just one of its assets.
Analysts Estimate Arvinas, Inc. (ARVN) to Report a Decline in Earnings: What to Look Out for
04:07pm, Tuesday, 27'th Jul 2021
Arvinas, Inc. (ARVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arvinas, Inc. (ARVN) Moves 13% Higher: Will This Strength Last?
05:23am, Monday, 26'th Jul 2021
Arvinas, Inc. (ARVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t
Arvinas (ARVN), Pfizer Team up for Breast Cancer Therapy
12:16pm, Friday, 23'rd Jul 2021
Arvinas (ARVN) collaborates with Pfizer for its investigational breast cancer candidate, ARV-471. Pfizer is also set to acquire an equity stake in Arvinas.
Why Arvinas Jumped 10% Today
03:21pm, Thursday, 22'nd Jul 2021
The smaller biopharma outfit just inked an encouraging deal with an industry powerhouse.
ARVN Stock Increased Over 16% Intraday: Why It Happened
01:37pm, Thursday, 22'nd Jul 2021
The stock price of Arvinas Inc (NASDAQ: ARVN) increased by over 16% during intraday trading. This is why it happened.
Arvinas, Pfizer Announce $2.4B Licensing Agreement For Protein-Degrader Based Breast Cancer Therapy
09:25am, Thursday, 22'nd Jul 2021
Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) have collaborated to develop and commercialize ARV-471, an investigational oral PROTAC (PROteolysis TArgeting Chimera) estrogen receptor prot
Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New Haven
05:19pm, Monday, 07'th Jun 2021
NEW HAVEN, Conn., June 07, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today join
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising Investment
10:27am, Wednesday, 02'nd Jun 2021
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?
03:10am, Friday, 21'st May 2021
Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?
